Overview
Status
Active
Registry date
2015-03-23
Share capital
54,000.00 PLN
Registered address
ul. Grójecka 214/119, 02-390 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Jerzy Wiesław Sławiński – President of the Management Board
Manner of representation
Each member of the management board acting independently is authorized to submit declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Baradziejage 66 | 270 | $7,293.35 | 50% |
Jerzy Wiesław Sławińskiage 76 | 270 | $7,293.35 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of DE Medicine Regenerative focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on March 23, 2015.
The headquarters is located at: ul. Grójecka 214, 02-390 Warszawa.
The share capital of the company is PLN 54,000 (approx. $14,587).
Last updated: 2026-06-03